Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (terbuka di window baru)

Ball AM, Winstead PS.

Sumber‎: Pharmacotherapy 2008;28(11):1383-90.

Index‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (terbuka di window baru)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (terbuka di window baru)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Sumber‎: Transplant Proc 2015;47(8):2548-51.

Index‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (terbuka di window baru)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (terbuka di window baru)

Charles A, Purtill M, Napolitano LM.

Sumber‎: Anaesth Intensive Care 2006;34(6):793-6.

Index‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (terbuka di window baru)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (terbuka di window baru)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Sumber‎: Crit Care Med 1999;27(11):2346-50.

Index‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (terbuka di window baru)

The role of erythropoietin therapy in the critically ill. (terbuka di window baru)

Corwin HL.

Sumber‎: Transfus Med Rev 2006;20(1):27-33.

Index‎: PubMed 16373185

DOI‎: 10.1016/j.tmrv.2005.08.002

https://www.ncbi.nlm.nih.gov/pubmed/16373185 (terbuka di window baru)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (terbuka di window baru)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Sumber‎: Crit Care 2005;9(5):R508-15.

Index‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (terbuka di window baru)

Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. (terbuka di window baru)

Khalafallah AA, Yan C, Al-Badri R, Robinson E, Kirkby BE, Ingram E, Gray Z, Khelgi V, Robertson IK, Kirkby BP.

Sumber‎: Lancet Haematol 2016;3(9):e415-25.

Index‎: PubMed 27570088

DOI‎: 10.1016/S2352-3026(16)30078-3

https://www.ncbi.nlm.nih.gov/pubmed/27570088 (terbuka di window baru)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (terbuka di window baru)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Sumber‎: Intensive Care Med 2013;39(11):1896-908.

Index‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (terbuka di window baru)

An international consensus statement on the management of postoperative anaemia after major surgical procedures. (terbuka di window baru)

Muñoz M, Acheson AG, Bisbe E, Butcher A, Gómez-Ramírez S, Khalafallah AA, Kehlet H, Kietaibl S, Liumbruno GM, Meybohm P, Rao Baikady R, Shander A, So-Osman C, Spahn DR, Klein AA

Sumber‎: Anaesthesia 2018;73(11):1418-31.

Index‎: PubMed 30062700

DOI‎: 10.1111/anae.14358

https://www.ncbi.nlm.nih.gov/pubmed/30062700 (terbuka di window baru)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (terbuka di window baru)

Posluszny JA Jr, Napolitano LM.

Sumber‎: Transfusion 2014;54(12):3026-34.

Index‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (terbuka di window baru)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (terbuka di window baru)

Price S, Pepper JR, Jaggar SI.

Sumber‎: Anesth Analg 2005;101(2):325-7.

Index‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (terbuka di window baru)

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. (terbuka di window baru)

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Sumber‎: J Am Heart Assoc 2015;4(6):e002066.

Index‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 (terbuka di window baru)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (terbuka di window baru)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Sumber‎: Br J Anaesth 2005;94(4):442-4.

Index‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (terbuka di window baru)

Transfusion-free management of gastrointestinal bleeding: the experience of a Bloodless Institute. (terbuka di window baru)

Sharma P, Barajas FJ, Krishnamoorthy P, Campo LM, Blumenthal E, Spinnell M.

Sumber‎: J Clin Gastroenterol 2015;49(3):206-11.

Index‎: PubMed 25144897

DOI‎: 10.1097/MCG.0000000000000200

https://www.ncbi.nlm.nih.gov/pubmed/25144897 (terbuka di window baru)

Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial. (terbuka di window baru)

Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL.

Sumber‎: Crit Care Med 2006;34(9):2310-6.

Index‎: PubMed 16878035

DOI‎: 10.1097/01.CCM.0000233873.17954.42

https://www.ncbi.nlm.nih.gov/pubmed/16878035 (terbuka di window baru)